Review
Biosynthesis of amphetamine analogs
in plants
1 2 3 2
Jillian M. Hagel , Raz Krizevski , Fre´ de´ ric Marsolais , Efraim Lewinsohn and
1
Peter J. Facchini
1
Department of Biological Sciences, University of Calgary, Calgary, AB, T2N 1N4, Canada
2
Department of Aromatic, Medicinal and Spice Crops, Newe Ya’ar Research Center, Agricultural Research Organization,
PO Box 1021, Ramat Yishay 30095, Israel
3
Southern Crop Protection and Food Research Centre, Agriculture and Agri-Food Canada, London, Ont, N5 V 43T, Canada
Amphetamine analogs are produced by plants in the microorganisms for the de novo production of pseudoephed-
genus Ephedra and by Catha edulis, and include the rine and ephedrine. The potential acceptance of substituted
widely used decongestants and appetite suppressants precursors by such enzymes and the possible occurrence of
pseudoephedrine and ephedrine. A combination of yeast catalysts from any organism with the serendipitous capacity
(Candida utilis or Saccharomyces cerevisiae) fermenta- to modify amphetamine analogs might provide an unprece-
tion and subsequent chemical modification is used for dented opportunity for the commercial production of some
the commercial production of these compounds. The pharmaceuticals in synthetic biosystems.
availability of certain plant biosynthetic genes would
facilitate the engineering of yeast strains capable of de Amphetamine analogs in plants
novo pseudoephedrine and ephedrine biosynthesis. Khat is a flowering perennial shrub with a long history of
Chemical synthesis has yielded amphetamine analogs cultivation in East Africa and the Arabian Peninsula.
with myriad functional group substitutions and diverse Evidence suggests that the traditional practice of chewing
pharmacological properties. The isolation of enzymes khat leaves as part of social affairs dates back at least 1000
with the serendipitous capacity to accept novel sub- years [4] and might even pre-date the use of coffee [5]. The
strates could allow the production of substituted presence of (S)-cathinone in young khat leaves imparts a
amphetamines in synthetic biosystems. Here, we review mild euphoria and stimulating effect, making khat a pop-
the biology, biochemistry and biotechnological potential ular concentration aid for students and scholars. Although
of amphetamine analogs in plants. use of the plant has recently generated health concerns,
studies involving short- and long-term effects of khat
Plants and the biotechnological potential for chewing have been incomplete or controversial [6]. Khat
amphetamine analog biosynthesis possession is strictly illegal in many Western countries.
Plants produce a vast array of specialized nitrogenous Notable exceptions include the UK and Holland, where
metabolites, including a wide variety of alkaloids and glu- khat use is entirely unregulated [4]. Ephedra sinica,
cosinolates [1,2]. Substituted amphetamines, which are also known as Ma Huang in Chinese medicine, also has a long
called phenylpropylamino alkaloids, are a diverse group of history of traditional use, particularly in the treatment
nitrogen-containing compounds that feature a phenethyla- of bronchial asthma, coughs, nasal congestion, headaches
mine backbone with a methyl group at the a-position rela- and edema [7]. (1S,2S)-Pseudoephedrine is a common
tive to the nitrogen (Figure 1). Countless variation in ingredient in many over-the-counter cold or allergy for-
1 1
functional group substitutions has yielded a collection of mulations, including Claritin D , Contac and various
1
synthetic drugs with diverse pharmacological properties as Sudafed products. (1R,2S)-Ephedrine is marketed as
stimulants, empathogens and hallucinogens [3]. Although an anticongestant, diet aid and sports-enhancing drug,
amphetamine (1-phenylpropan-2-amine) and most analogs although its availability is more restricted. (S)-Cathinone,
are synthetic, several well-known phenylpropylamino alka- (1S,2S)-pseudoephedrine and (1R,2S)-ephedrine are sym-
loids are produced by Catha edulis, commonly known as pathomimetic agents acting with either, or a combination
khat, and by members of the genus Ephedra (Figure 1). of: (i) direct agonist activity at adrenergic receptors [8]; (ii)
Although the widely used decongestant pseudoephedrine indirect activity through the release of noradrenaline from
and the diet aid ephedrine occur in several Ephedra species, sympathetic neurons; or (iii) activity at currently uniden-
commercial production of these alkaloids involves a combi- tified receptors [9]. Ephedrine causes central serotonin
nation of fermentation and chemical synthesis. The forma- and dopamine release [10], which might contribute to its
tion of amphetamine analogs in plants has been partially purported addictive nature [11].
characterized at the biochemical level. The availability of (S)-Cathinone is the principal psychostimulant in
the key biosynthetic genes of amphetamine analog biosyn- khat and accumulates primarily in young leaves
thesis in plants could provide opportunities to engineer (Figure 1), whereas (1S,2S)-norpseudoephedrine (cathine)
and (1R,2S)-norephedrine occur throughout all the aerial
Corresponding author: Facchini, P.J. ([email protected]). organs of the plant [12]. Ephedra species such as E. sinica
404 doi:10.1016/j.tplants.2012.03.004 Trends in Plant Science, July 2012, Vol. 17, No. 7
Review Trends in Plant Science July 2012, Vol. 17, No. 7
Ephedra spp. Catha edulis O
NH2 OH H α N β (S)-cathinone OH (1R,2S)-ephedrine NH2
OH H (1R,2S)-norephedrine 2 N 1 OH
NH2 (1S,2S)-pseudoephedrine
(1S,2S)-pseudonorephedrine
TRENDS in Plant Science
Figure 1. Naturally occurring substituted amphetamines in Ephedra species and Catha edulis (khat). (S)-Cathinone imparts a mild stimulant effect upon chewing young khat
leaves, whereas N-methylated alkaloids (1R,2S)-ephedrine and (1S,2S)-pseudoephedrine in plants such as Ephedra sinica are effective nasal decongestants.
and E. distachya have N-methylated versions of these com- a-carbon. Such structural similarities promoted the initial
pounds, including (1R,2S)-ephedrine and (1S,2S)-pseudo- hypothesis that amphetamine analogs, such as ephedrine,
ephedrine (Figure 1) [13]. The occurrence of a hydroxyl were derived directly from Phe [27] or by reaction of a Phe-
group at the b-carbon of norephedrine and ephedrine alka- derived phenethylamine with a formate-derived one-car-
loids forms a second chiral center, creating diastereomer bon unit [28]. However, early pulse-labeling studies using
pairs. In the mature stems of E. sinica, a second N-methyl C. edulis [29] and Ephedra distachya [30,31] established
group may be present, forming (1R,2S)-N-methylephedrine that only the benzylic (i.e. C6–C1) component of ephedrine
or (1S,2S)-N-methylpseudoephedrine. Ephedrine has also alkaloids is derived from Phe. Interestingly, this finding
been reported in Sida cordifolia, an important plant in implied that Phe first undergoes deamination and side-
Ayurvedic medicine [14,15], and other amphetamine ana- chain shortening, followed by chain lengthening and ream-
logs have been detected in Acacia berlandieri [16] and ination (Figure 2). In support of this model, authors
Acacia rigidula [17]. Related compounds found in plants showed that cinnamic acid, benzoic acid and benzaldehyde
include the stimulant synephrine, a popular diet aid and were each efficiently incorporated into ephedrine [30,31].
sports-enhancing drug present in bitter orange (Citrus aur- Nearly two decades later, it was shown that the remaining
antium) [18]; mescaline, a hallucinogen derived from the C2–C3 unit was derived from pyruvic acid [32,33]
peyote cactus (Lophophora williamsii) [19]; and adrenalin, (Figure 2). Further tracer experiments supported benzoic
found in trace amounts in cacti and other plants [20]. acid (or benzoyl-CoA) over benzaldehyde as the C6–C1
Khat is a member of the Celestraceae, an angiosperm molecule undergoing carboligation with pyruvic acid
family of dicotyledonous vines, shrubs and small trees [21]. [34]. In other systems, such as yeast, the carboligation of
Conversely, the genus Ephedra is the sole member of the benzaldehyde and pyruvic acid, catalyzed by a thiamin
Ephedraceae family, which in turn represents one of three diphosphate (ThDP)-dependent enzyme, is a well-charac-
families in the order Gnetales. Although generally viewed terized reaction [35,36]. Whether benzoic acid (benzoyl-
as gymnosperms, members of the Gnetales share certain CoA) or benzaldehyde directly supplies the C6–C1 unit of
features with angiosperms, such as vessel elements, chla- ephedrine alkaloids remains an open question [37].
mys-surrounded ovules and double fertilization [22]. Such The molecular biochemical basis of substituted amphet-
characteristics gave rise to the ‘anthophyte’ hypothesis amine biosynthesis in khat and Ephedra species is largely
[23], which held that Gnetales were a sister taxa to flower- unknown. Only the initial step [the deamination of Phe by
ing plants. However, recent molecular-based evidence has phenylalanine ammonia lyase (PAL)] has been character-
consistently placed Gnetales within the division Coniferae ized at the molecular level in E. sinica [38]. Figure 3
(i.e. conifers) as a sister group to the Pinaceae, or pine illustrates the proposed biosynthesis of ephedrine alka-
family [24,25]. The restricted occurrence of substituted loids based on molecular evidence gathered from other
amphetamine biosynthesis in both angiosperms and gym- plant species and biochemical studies of khat or E. sinica
nosperms suggests the convergent recruitment of required [12,13,38]. Several enzymes involved in benzoic acid bio-
biosynthetic genes [26]. The independent evolution of key synthesis, including 4-coumaroyl-CoA ligase (4CL) [39],
enzymes or whole pathways within plant specialized me- benzoyl-CoA ligase (BZO1) [40], a 3-ketoacyl-CoA thiolase
tabolism is not uncommon. For example, purine alkaloids (KAT1) [41] and two distinct dehydrogenases from snap-
(e.g. caffeine), pyrrolizidine alkaloids and various plant dragon (Antirrhinum majus) (BALDH) [42] and Arabidop-
pigments are likely products of convergent evolution [26]. sis (Arabidopsis thaliana) (AAO4) [43], have been cloned
and characterized from plants that produce floral volatiles
Biosynthesis of substituted amphetamines in plants or glucosinolates. Studies of benzoic acid biosynthesis in
The biosynthesis of naturally occurring substituted these plants have revealed at least two possible courses
amphetamines in plants begins with L-phenylalanine of Phe side-chain shortening: the b-oxidative and non-b-
(Phe) as the precursor. Similar to amphetamine, Phe com- oxidative routes [44] (Figure 3). Alternatively, benzalde-
prises a C6–C3 backbone, with an amino group at the hyde might be formed via phenylpyruvate, which is a
405
Review Trends in Plant Science July 2012, Vol. 17, No. 7
An enzyme catalyzing the condensation of benzoic acid,
benzoyl-CoA or benzaldehyde with pyruvate has not yet
been isolated from substituted amphetamine-producing
plants, although a ThDP-dependent pyruvate decarboxyl-
ase (PDC; EC 4.1.1.1) or an acetohydroxyacid synthase
(AHAS; EC 2.2.1.6) have been suggested [33]. These two
Deamination distantly related enzymes [47] share the common step of
pyruvate decarboxylation. However, whereas PDCs gener-
ally decompose pyruvate to acetaldehyde and CO2 [48],
AHASs catalyze carboligation reactions, forming either
acetolactate or acetohydroxybutyrate products as part of
branched-chain amino acid biosynthesis [36]. Members of
β-Oxidation both enzyme classes have shown carboligase activity toward
benzaldehyde, yielding (R)-phenylacetylcarbinol (R-PAC)
and a variety of other products [48,49]. The possibility that
such reaction products are formed in khat or Ephedra
species is acknowledged in Figure 3. It is currently postu-
lated that 1-phenylpropane-1,2-dione is a direct precursor to
amphetamine analogs in plants [12,13,34,37]. This diketone
Carboligation
has been isolated from khat leaves [12] and young E. sinica
stems [13]. 1-Phenylpropane-1,2-dione subsequently under-
goes transamination to yield (S)-cathinone, which is con-
verted to (1S,2S)-cathine or (1R,2S)-norephedrine by
NADH-dependent reduction (Figures 2 and 3). Although
the transamination step has not been characterized, (S)-
Transamination cathinone reductase activity was reported recently in E.
sinica stems [13] and khat leaves [12]. S-Adenosylmethio-
nine (SAM)-dependent N-methylation completes the path-
way in Ephedra species, yielding (1R,2S)-ephedrine and its
diastereomer. N-Methylation activity has been detected in
cell-free extracts of E. sinica stems [13]. By contrast, the end
products cathine and (1R,2S)-norephedrine do not undergo
Reduction
N-methylation in khat.
Beyond PAL, no genes encoding enzymes involved in
amphetamine analog biosynthesis have been isolated. For
the purposes of gene discovery, we recently established a
functional genomics platform enabling the identification of
key biosynthetic gene candidates from khat [37] and E.
N-methylation sinica, including deep sequence resources based on RNA-
seq technology [50]. The availability of sequence resources
will provide homologs or entirely novel enzymes potential-
ly involved in alkaloid biosynthesis. For example, the
amino acid sequences of enzymes listed in Table 1 can
serve as queries to identify homologs in khat or E. sinica,
TRENDS in Plant Science and functional analyses can be used to establish their roles
in substituted amphetamine biosynthesis (Figure 3).
Figure 2. Schematic representation of substituted amphetamine biosynthesis.
Although metabolism begins with a C6–C3 backbone including a nitrogen (L- Understanding the pathway at the molecular biochemical
phenylalanine), deamination and chain shortening, followed by chain lengthening
level is critical for the development of novel biotechnologi-
and an amino transfer, are necessary to build an amphetamine framework.
cal tools with potential applications in the pharmaceutical
Deamination of phenylalanine yields cinnamic acid, which undergoes chain
shortening from C6–C3 to C6–C1 by either b-oxidative or non-b-oxidative industry.
pathways, generating benzoic acid or a derivative (Figure 3). Reforming of a C6–
C3 backbone is then achieved by carboligation with pyruvate, yielding 1-
Potential biotechnological applications
phenylpropane-1,2-dione. Nitrogen is reintroduced by transamination to
cathinone, followed by reduction to cathine and/or norephedrine and N- Three different methodologies exist for the commercial
methylation to pseudoephedrine/ephedrine. N-Methylation occurs in Ephedra
production of ephedrine and related alkaloids: (i) historic
species, but not in khat. Color coding: black, carbon; red, oxygen; blue, nitrogen.
practices have included extraction from plants such as
E. sinica, a method still used for herbal formulations
transamination product of Phe. This route occurs in lactic and various products containing Ma Huang. Alkaloids
acid bacteria [45], but has not been confirmed in plants. are obtained by an initial treatment with alkali, followed
Nonetheless, the transamination of Phe to phenylpyruvate by extraction with an organic solvent. However, extraction
has recently been demonstrated, which might lead to the from plant sources is laborious, time-consuming and rela-
formation of benzaldehyde in melon fruit [46]. tively expensive [51]; (ii) in addition to natural sources,
406
Review Trends in Plant Science July 2012, Vol. 17, No. 7
Table 1. Level of characterization for enzymes with putative or established roles in phenylpropanoid, benzoic acid and
amphetamine analog metabolism in plants
Enzyme activity Level of characterization in different plants Refs
Enzymatic Molecular genetic
Phenylalanine ammonia lyase Numerous species Numerous species, including Ephedra sinica [38]
a
Cinnamoyl-CoA ligase Numerous species Numerous species
Cinnamoyl-CoA hydratase Hypericum androsaemum Not characterized [93]
Retro-aldol cleavage H. androsaemum Not characterized [93]
Benzaldehyde dehydrogenase H. androsaemum Antirrhinum majus [42,43,93,94]
Sorbus aucuparia Arabidopsis thaliana
Benzoyl-CoA ligase Clarkia breweri A. thaliana [40,95]
3-Ketoacyl-CoA thiolase Not characterized Petunia hybrida [41]
ThDP-dependent carboligase Hypothesized in plants but well Not characterized [33,34,37]
established in microorganisms
Transaminase Not characterized Not characterized
Reductase Catha edulis Not characterized [12,13]
E. sinica
N-Methyltransferase E. sinica Not characterized [13]
a
Including 4-coumaroyl-CoA ligases with cinnamoyl-CoA ligase activity.
de novo chemical syntheses generating racemic mixtures with organic solvents from the fermentation broth and
have long been established [52]; and (iii) a third methodo- chemically converted to an imine intermediate by reaction
logy involves the enantioselective production of (1R,2S)- with methylamine (Figure 4a). Reduction of the imine to
ephedrine from R-PAC [51]. The current commercial man- (1R,2S)-ephedrine is completed using hydrogen and a
ufacture of (1R,2S)-ephedrine and (1S,2S)-pseudoephed- metal catalyst. A recent patent outlined a process wherein
rine relies largely on this semi-synthetic process. The idea reductive amination of R-PAC may be conducted in the
of using benzaldehyde-supplemented microbial fermenta- presence of supercritical carbon dioxide, thereby circum-
tion to produce R-PAC, followed by reductive amination to venting the use of conventional organic solvents [60].
yield ephedrine alkaloids, was patented nearly 80 years (1S,2S)-Pseudoephedrine is produced from (1R,2S)-ephed-
ago [53] and is still used today (Figure 4a). rine by Welsh rearrangement [51].
Modern industrial production of ephedrine and Emerging synthetic biosystems for industrial alkaloid
pseudoephedrine production
Many microbes have the capacity to perform a biotransfor- The fact that the industrial production of (1R,2S)-ephedrine
mation that yields R-PAC, although most processes have and (1S,2S)-pseudoephedrine is at least partially completed
relied on the use of either Candida utilis or Saccharomyces through fermentation raises the intriguing possibility of
cerevisiae [54]. To better understand biotransformation employing synthetic biology for the production of these
processes, in vitro studies with yeast extract and/or puri- alkaloids. In this context, synthetic biology would involve
fied PDC enzyme have been conducted. Such studies show the expression in microbes of biosynthetic genes derived
that, under anaerobic conditions, PDC (native or engi- from plants or other organisms for the production of key
neered) converts exogenously supplied benzaldehyde and intermediates or amphetamine end products. Parts or even
endogenously available pyruvate to R-PAC [55]. As a whole pathways may be transferred from plants to systems
potential alternative to whole-cell biotransformation, pro- such as yeast, which permits the use of scalable fermenta-
cesses involving purified PDC have been evaluated and tion [61]. For example, recent efforts toward the production
shown to produce R-PAC levels up to 28 g/L with conver- of benzylisoquinoline alkaloids (BIAs), such as codeine and
sion rates of 90–95% [55]. Several undesired side-reactions morphine, in microorganisms have led to the production of a
are known to occur, especially the oxidation of benzalde- key biosynthetic intermediate, reticuline, from a norlauda-
hyde to benzyl alcohol by native oxidoreductases. However, nosoline precursor by heterologously expressing four genes
the greatest obstacle is that carboligation of benzaldehyde derived from BIA-producing plants [62–64]. Furthermore,
with pyruvate is normally a minor side-reaction of micro- the use of a human cytochrome P450 (CYP2D6) to convert
bial PDCs; in fact, this reaction is generally not observed (R)-reticuline to the promorphinan alkaloid salutaridine
unless specific conditions are used (e.g. the presence of [63] highlighted the use of surrogate genes sourced from
large amounts of acetaldehyde, the predominant reaction non-plant organisms. Beyond BIAs, synthetic biology has
product) that subsequently elevate R-PAC production to been used for the production of precursors to important
1% [48]. Continued engineering of microbial PDCs over pharmaceuticals such as the antimalarial agent artemisinin
the past two decades has yielded enzyme variants with [65], the anticancer drug taxol [66] and other small meta-
altered product profiles, increased stability and enhanced bolites [67]. Additionally, heterologous gene expression in
carboligation potential [48,49,56–59]. Recently, an active microbes has been used for the production of dietary omega-
site variant of Zymomonas mobilis PDC was shown to 3 fatty acids [68,69] and biofuels [70]. Synthetic biology is
prefer carboligation over aldehyde formation by nearly also used for the production of halogenated or otherwise non-
100-fold [48]. Following its formation, R-PAC is extracted natural metabolites with potential clinical relevance [61].
407
Review Trends in Plant Science July 2012, Vol. 17, No. 7
O
OH
NH2 L-phenylalanine β-Oxidative CoA-dependent pathway PAL
O O Non-β-oxidative CoA ligase CoA-independent pathway OH S-CoA
CoASH H2O trans-Cinnamic trans-Cinnamoyl-CoA acid H2O Cinnamoyl- CoA hydratase Hydration OH O OH O Retro-aldol OH cleavage S-CoA
3-Hydroxy-3-phenylpropionic acid 3-hydroxy-3-phenylpropionyl-CoA
O NAD Retro-aldol cleavage NADH Dehydrogenase OH O O O O
S-CoA S-CoA
Benzaldehyde 3-oxo-3-phenylpropionyl-CoA
Dehydrogenase Thiolase CoASH NAD Thioesterase O NADH O O CoA ligase S-CoA OH S-CoA
Benzoic acid CoASH Benzoyl-CoA
Pyruvate Pyruvate
ThDP-dependent enzyme CO ThDP-dependent enzyme CO2 2 O
HO H
O O 1-phenylpropane-1,2-dione (S)-phenylacetyl- carbinol Transaminase H OH O
NH2 O (R)-phenylacetyl- carbinol (S)-cathinone
O Reductase NADH Reductase
+ NAD HO H OH OH
NH2 NH2 (S)-2-hydroxy- propiophenone (1S,2S)-pseudonorephedrine (1R,2S)-norephedrine O (cathine) SAM SAM OH H SAH N-methyltransferase SAH N-methyltransferase
(R)-2-hydroxy- OH OH H H propiophenone N N
(1S,2S)-pseudoephedrine (1R,2S)-ephedrine
TRENDS in Plant Science
Figure 3. Proposed biosynthetic routes leading from L-phenylalanine to substituted amphetamines in khat and Ephedra species. A CoA-independent, non-b-oxidative
pathway of L-phenylalanine side-chain shortening is shown in blue, whereas a CoA-dependent, b-oxidative route is shown in purple. Red arrows indicate an alternative
CoA-dependent, non-b-oxidative route suggested to occur in some plants [44]. Benzoic acid or benzoyl-CoA undergoes condensation with pyruvate, a reaction putatively
catalyzed by a ThDP-dependent enzyme [34]. Benzaldehyde may also undergo carboligation, producing numerous possible products (pink), a reaction observed in
numerous microbes. It is not yet firmly established which carboligation products give rise to downstream alkaloids, although 1-phenylpropane-1,2-dione is thought to be an
408
Review Trends in Plant Science July 2012, Vol. 17, No. 7
(a) O (b) O H N NH2 HO + O Pyruvate Benzaldehyde (R)-methamphetamine (S)-amphetamine (decongestant) (attention deficit hyperactivity Pyruvate disorder treatment) decarboxylase OH H N NH2 Fermentation
O (R)-phenylacetylcarbinolyla Mephentermine Phentermine (vasoconstrictor) (obesity treatment)
Methylamine -H2O O O H N H OH N N
Cl Bupropion Methoxyphenamine Intermediateer (antidepressant) (bronchodilator)
Reduction H2 / Pt O OH CH H N C N N Chemical Selegiline Amfepramone EphedrineEp (Parkinson’s disease treatment) (obesity treatment) H Welsh O H rearrangement N OH H2N H N NH2
H H Pyrovalerone Tranylcipromine Pseudoephedrine (chronic fatigue treatment) (antianxiety)
TRENDS in Plant Science
Figure 4. Industrial production of ephedrine and pseudoephedrine, and the structures of several synthetic amphetamine-type pharmaceuticals. (a) Industrial production of
(1R,2S)-ephedrine and (1S,2S)-pseudoephedrine relies on both fermentation and synthetic chemistry. Benzaldehyde fed to yeast cultured under anaerobic conditions
undergoes pyruvate decarboxylase (PDC)-catalyzed carboligation with endogenous pyruvate, yielding (R)-phenylacetylcarbinol (R-PAC). R-PAC is extracted from the
fermentation broth and subjected to reductive amination using methylamine in combination with hydrogen and a metal catalyst. (1S,2R)-pseudoephedrine is produced
from its diastereomer via Welsh rearrangement. (b) Examples of synthetic, pharmaceutically important substituted amphetamines. Functional genomics could potentially
provide new tools for the enzymatic production of ephedrine, pseudoephedrine and novel pharmaceuticals.
Halogenation, in particular, may impact the pharmacologi- analog substrates with up to sixfold greater product yields
cal profile of a compound [71] and expand possibilities for compared with wild-type enzyme [48].
novel drug development. Recently, chlorination biosynthet-
ic genes from soil bacteria were introduced into the medici- Potential for commercial ephedrine production using
nal plant Catharanthus roseus, a source of monoterpene synthetic biosystems
indole alkaloids (MIAs), such as the anticancer agent vin- The potential application of synthetic biology to (1R,2S)-
blastine, resulting in the production of several novel halo- ephedrine production would require the availability of
genated MIAs [72]. Enzyme engineering has led to catalytic specific molecular tools, sourced either from amphetamine
variants with altered substrate acceptance profiles, en- analog-producing plants, such as E. sinica, or other organ-
abling more facile halogenation of MIA precursors [73,74]. isms. For example, a transaminase capable of accepting
Notably, the approach of enzyme engineering has similarly hydroxyketone substrates, such as R-PAC, could generate
been applied in the context of R-PAC production. Recently, a (1R,2S)-norephedrine. Conversely, S-PAC, produced by
PDC variant was found to accept halogenated benzaldehyde certain PDC mutants [49], could be transaminated to
immediate precursor to (S)-cathinone via transamination [13]. (S)-Cathinone is reduced to (1S,2S)-cathine and (1R,2S)-norephedrine. N-Methylation occurs in Ephedra
species, but not in khat. Activity has been detected for enzymes highlighted in yellow, and corresponding genes are available for enzymes highlighted in green. Enzymes
highlighted in pink have not been detected. Note that PAL is the sole enzyme characterized at the molecular level in substituted amphetamine-producing plant species [38].
Abbreviations: CoA, Coenzyme A; PAL, phenylalanine ammonia lyase; ThDP, thiamine diphosphate.
409
Review Trends in Plant Science July 2012, Vol. 17, No. 7
(1S,2S)-norpseudoephedrine. Although such transaminase raises the intriguing possibility of coupling fermentation-
activity has yet to be reported in plants, amino transfer based ephedrine production with the use of novel enzymes
reactions involving hydroxyketone substrates and ami- possessing natural or engineered functions, enabling the
noalcohol products have been reported in microorganisms partial or complete biosynthesis of existing or new pharma-
[75,76]. An N-methyltransferase step would complete the ceuticals. For example, engineered PDC from Zymomonas
formation of (1R,2S)-ephedrine and its diasteriomer. Al- mobilis was shown to accept chlorinated benzaldehyde deri-
though genes encoding a transaminase and an N-methyl- vatives [48], indicating potential for the downstream pro-
transferase have yet to be cloned from khat or E. sinica, the duction of drugs with halogenated ring systems. Enzymes
current availability of functional genomics resources from catalyzing reductive dehydroxylation (a reaction hypotheti-
these plants provide a platform for the discovery of such cally required to generate key compounds from the ephed-
tools. Genes encoding numerous enzymes involved in benz- rine precursor) have been isolated from pathogenic [86] and
aldehyde biosynthesis have been isolated from other gut bacteria [87]. Several different enzymes catalyze aro-
plants, such as Arabidopsis and snapdragon, raising the matic ring hydroxylation, including ortho-hydroxylases
possibility of integrating these ‘upstream’ components into from plants [88]. The formation of C–C bonds toward the
a microbial-based system for the de novo production of production of functionalized amphetamine analogs is
ephedrine alkaloids [38–43]. Although de novo production uniquely challenging from a biochemical point of view,
of benzaldehyde in microorganisms is a rather ambitious although many examples of carboligating enzymes exist
goal with envisioned caveats such as potential toxicity [77], [89]. Although few enzymes are known to accept (1R,2S)-
such an approach would ultimately preclude the need for ephedrine and related alkaloids, the availability of such
chemical precursors. Furthermore, the use of heterologous- biocatalysts from plants or other organisms would be in-
ly expressed enzymes downstream of PAC would preclude valuable toward the metabolic engineering of amphetamine
the need for further chemical processing. analog biosynthesis.
Synthetic pathways for amphetamine analog Concluding remarks
biosynthesis in microbes Recent advances in the production of plant specialized
Beyond (1R,2S)-ephedrine and (1S,2S)-pseudoephedrine, metabolites in synthetic biosystems [63,90,91] have creat-
myriad other substituted amphetamines have important ed new opportunities for improving strategies for the
pharmaceutical applications. The stereochemistry at the production of pharmaceuticals and other high-value com-
a-carbon is often a key determinant of pharmacological pounds. The existing fermentation-based commercial prep-
activity, with (S)-enantiomers being more potent. For ex- aration of pseudoephedrine and ephedrine could benefit
ample, (S)-amphetamine, commonly known as d-amphet- immensely from the isolation of plant genes involved in the
amine or dextroamphetamine, displays five times greater biosynthesis of these substituted amphetamines. Broader
psychostimulant activity compared with its (R)-isomer [78]. surveys targeting the identification of modifying enzymes
Most such molecules are produced exclusively through coupled with the possible acceptance of substituted pre-
chemical syntheses and many are prescribed widely in cursors by key plant enzymes would extend the bioproces-
modern medicine. For example, (S)-amphetamine sing potential to a wide range of presently synthetic
1 1
(Figure 4b), a key ingredient in Adderall and Dexedrine , amphetamine analogs.
is used to treat attention deficit hyperactivity disorder
(ADHD) [79]. N-Methylated amphetamine is known as Note added in the proof
methamphetamine, which is prescribed under the trade Recently, targeted metabolite profiling and comparative
1
name Desoxyn for the treatment of ADHD and exogenous biochemical analyses were used to show that benzaldehyde
obesity. The (R)-enantiomer of methamphetamine is the is a direct precursor to ephedrine alkaloids in Ephedra
1
active ingredient in Vicks Vapor Inhaler , a nasal decon- sinica [92]. This finding was accompanied by the detection
gestant sold over-the-counter in the USA and other coun- of ThDP-dependent carboligase activity with benzaldehyde
tries [80] (Figure 4b). Bupropion is prescribed extensively as the substrate.
under a variety of different trade names as an antidepres-
Acknowledgments
sant [81] and, more recently, a smoking cessation aid [82].
This work was supported by a grant from the Binational Agricultural
Selegiline, a drug used for the treatment of early-stage
Research and Development Fund (CA-9117-09). PJF holds the Canada
Parkinson’s disease and senile dementia [83], acts as a
Research Chair in Plant Metabolic Processes Biotechnology.
monoamine oxidase inhibitor and neuroprotective agent.
Phentermine and diethylpropion are prescribed for short- References
1 Ziegler, J. and Facchini, P.J. (2008) Alkaloid biosynthesis: metabolism
term use in the treatment of obesity [84], and mephenter-
and trafficking. Annu. Rev. Plant Biol. 59, 735–769
mine is a vasoconstrictor used to treat hypotension [85].
2 Sonderby, I.E. et al. (2010) Biosynthesis of glucosinolates – gene
Various structural differences exist between the compounds
discovery and beyond. Trends Plant Sci. 15, 283–290
shown in Figure 4b and ephedrine alkaloids, including the 3 Iversen, L. (ed.) (2006) Speed, Ecstasy, Ritalin: The Science of
lack of a hydroxyl function [at the b-carbon of (1R,2S)- Amphetamines, Oxford University Press
4 Klein, A. et al. (2009) Regulating khat – dilemmas and opportunities for
ephedrine; Figure 1], aromatic ring functionalization (e.g.
the international drug control system. Intl. J. Drug Policy 20, 509–513
methoxyphenamine and bupropion) and the addition of
5 Balint, E.E. et al. (2009) Khat – a controversial plant. Wien Klin.
various alkyl groups, perhaps precluding the industrial
Wochenschr. 121, 604–614
use of ephedrine alkaloids as precursors in most cases. 6 Mateen, F.J. and Cascino, G.D. (2010) Khat chewing: a smokeless gun?
However, structural relatedness between these compounds Mayo Clinic Proc. 85, 971–973
410
Review Trends in Plant Science July 2012, Vol. 17, No. 7
7 Liu, L. and Liu, Z., eds (2009) Essentials of Chinese Medicine, 36 Chipman, D.M. et al. (2005) Mechanisms of acetohydroxyacid
Springer-Verlag synthases. Curr. Opin. Chem. Biol. 9, 475–481
8 Docherty, J.R. (2008) Pharmacology of stimulants prohibited by the 37 Hagel, J.M. et al. (2011) Expressed sequence tag analysis of khat
World Anti-Doping Agency (WADA). Br. J. Pharmacol. 154, 606–622 (Catha edulis) provides a putative molecular biochemical basis for
9 Broadley, K.J. (2010) The vascular effects of trace amines and the biosynthesis of phenylpropylamino alkaloids. Genet. Mol. Biol.
amphetamines. Pharmacol. Therapeut. 125, 363–375 34, 640–646
10 Ellis, J.D. et al. (2011) Ephedrine decreases vesicular monoamine 38 Okada, T. et al. (2008) Molecular characterization of the phenylalanine
transporter-2 function. Synapse 65, 449–451 ammonia-lyase from Ephedra sinica. Biol. Pharm. Bull. 31, 2194–2199
11 Sulzer, D. (2011) How addictive drugs disrupt presynaptic dopamine 39 Schilmiller, A.L. et al. (2009) Mutations in the cinnamate 4-
neurotransmission. Neuron 69, 628–649 hydroxylase gene impact metabolism, growth and development in
12 Krizevski, R. et al. (2007) Developmental patterns of Arabidopsis. Plant J. 60, 771–782
phenylpropylamino alkaloids accumulation in khat (Catha edulis, 40 Kliebenstein, D.J. et al. (2007) Characterization of seed-specific
Forsk.). J. Ethnopharmacol. 114, 432–438 benzoyloxyglucosinolate mutations in Arabidopsis thaliana. Plant J.
13 Krizevski, R. et al. (2010) Composition and stereochemistry of 51, 1062–1076
ephedrine alkaloids accumulation in Ephedra sinica Stapt. 41 Van Moerkercke, A. et al. (2009) A plant thiolase involved in benzoic
Phytochemistry 71, 895–903 acid biosynthesis and volatile benzenoid production. Plant J. 60,
14 Marchei, E. et al. (2006) A rapid and simple procedure for the 292–302
determination of ephedrine alkaloids in dietary supplements by gas 42 Long, M.C. et al. (2009) Involvement of snapdragon benzaldehyde
chromatography-mass spectrometry. J. Pharmaceut. Biomed. 41, dehydrogenase in benzoic acid biosynthesis. Plant J. 59, 256–265
1633–1641 43 Ibdah, M. et al. (2009) An aldehyde oxidase in developing seeds of
15 Khatoon, S. et al. (2005) HPTLC method for chemical standardization Arabidopsis converts benzaldehyde to benzoic acid. Plant Physiol. 150,
of Sida species and estimation of the alkaloid ephedrine. J. Planar 416–423
Chromatr. 18, 364–367 44 Boatright, J. et al. (2004) Understanding in vivo benzenoid metabolism
16 Clement, B.A. et al. (1998) Toxic amines and alkaloids from Acacia in petunia petal tissue. Plant Physiol. 135, 1993–2011
rigidula. Phytochemistry 49, 1377–1380 45 Nierop-Groot, M.N. and de Bont, J.A.M. (1999) Involvement of
17 Clement, B.A. et al. (1997) Toxic amines and alkaloids from Acacia manganese in conversion of phenylalanine to benzaldehyde by lactic
berlandieri. Phytochemistry 46, 249–254 acid bacteria. Appl. Environ. Microbiol. 65, 5590–5593
18 Grazziotin Rossato, L. et al. (2011) Synephrine: from trace 46 Gonda, I. et al. (2010) Branched-chain and aromatic amino acid
concentrations to massive consumption in weight-loss. Food Chem. catabolism into aroma volatiles in Cucumis melo L. fruit. J. Exp.
Toxic. 49, 8–16 Bot. 61, 1111–1123
19 Aragane, M. et al. (2011) Peyote identification on the basis of 47 Green, J.B.A. (1989) Pyruvate decarboxylase is like acetolactate
differences in morphology, mescaline content, and trnL/trnF synthase (ILV2) and not like the pyruvate dehydrogenase E1
sequence between Lophophora williamsii and L. diffusa. J. Nat. subunit. FEBS Lett. 246, 1–5
Med. 65, 103–110 48 Meyer, D. et al. (2011) Conversion of pyruvate decarboxylase into an
20 Kulma, A. and Szopa, J. (2007) Catecholamines are active compounds enantioselective carboligase with biosynthetic potential. J. Am. Chem.
in plants. Plant Sci. 172, 433–440 Soc. 133, 3609–3616
21 Simmons, M.P. et al. (2008) Phylogeny of the Celastreae (Celastraceae) 49 Pohl, M. et al. (1998) Active site mutants of pyruvate decarboxylase
and the relationships of Catha edulis (qat) inferred from morphological from Zymomonas mobilis. A site-directed mutagenesis study of L112,
characters and nuclear and plastid genes. Mol. Phylogen. Evol. 48, I472, I476, E473, and N482. Eur. J. Biochem. 257, 538–546
745–757 50 Wang, Z. et al. (2009) RNA-seq: a revolutionary tool for
22 Friedman, W.E. and Carmichael, J.S. (1996) Double fertilization in transcriptomics. Nat. Rev. Genet. 10, 57–63
Gnetales: implications for understanding reproductive diversification 51 Shukla, V.B. and Kulkarni, P.R. (2000) L-Phenylacetylcarbinol (L-
among seed plants. Int. J. Plant Sci. 157, S77–S94 PAC): biosynthesis and industrial applications. World J. Microbiol.
23 Doyle, J.A. and Donoghue, M.J. (1986) Seed plant phylogeny and the Biotechnol. 16, 499–506
origin of angiosperms: an experimental cladistic approach. Bot. Rev. 52, 52 Manske, R.H.F. and Johnson, T.B. (1929) Synthesis of ephedrine and
321–431 structurally similar compounds. I. A new synthesis of ephedrine. J.
24 Chaw, S-M. et al. (2000) Seed plant phylogeny inferred from all three Am. Chem. Soc. 51, 580–582
plant genomes: monophyly of extant gymnosperms and origin of 53 Hinderbrandt, G. and Klavehn, W.E., E. Bilhuber. Manufacture of levo-
Gnetales from conifers. Proc. Natl. Acad. Sci. U.S.A. 97, 4086–4091 1-phenyl-2-methylaminopropanol-1, 1956950
25 Finet, C. et al. (2010) Multigene phylogeny of the green lineage reveals 54 Khan, T.R. and Daugulis, A.J. (2010) Application of solid-liquid TPPBs
the origin and diversification of land plants. Curr. Biol. 20, 2217–2222 to the production of L-phenylacetylcarbinol from benzaldehyde using
26 Pichersky, E. and Lewinsohn, E. (2011) Convergent evolution in plant Candida utilis. Biotechnol. Bioeng. 107, 633–641
specialized metabolism. Annu. Rev. Plant Biol. 62, 549–566 55 Rogers, P.L. et al. (1997) Biotransformation for L-ephedrine
27 Shibata, S. and Imaseki, I. (1956) Phytochemical investigation on production. Adv. Biochem. Eng. Biotechnol. 56, 33–59
cultivation of medicinal plants. Chem. Pharm. Bull. 4, 277–280 56 Bruhn, H. et al. (1995) The replacement of Trp392 by alanine influences
28 Shibata, S. et al. (1957) Investigation on cultivation of medicinal the decarboxylase/carboligase activity and stability of pyruvate
plants. XIV. On the alkaloid biogenesis in Ephedra. Chem. Pharm. decarboxylase from Zymomonas mobilis. Eur. J. Biochem. 234, 650–
Bull. 5, 594–597 655
29 Leete, E. (1958) Biogenesis of D-norpseudoephedrine in Catha edulis. 57 Goetz, G. et al. (2001) Continuous production of (R)-
Chem. Ind. 33, 1088–1089 phenylacetylcarbinol in an enzyme-membrane reactor using a potent
30 Yamasaki, K. et al. (1969) Biosynthesis of ephedrine in Ephedra: mutant of pyruvate decarboxylase from Zymomonas mobilis.
participation of a C6-C1 unit. Tetrahedron Lett. 47, 4099–4102 Biotechnol. Bioeng. 74, 317–325
31 Yamasaki, K. et al. (1973) Participation of C6-C1 unit in the 58 Baykal, A. et al. (2006) Synthesis with good enantiomeric excess of both
biosynthesis of ephedrine in Ephedra. Phytochemistry 12, 2877–2882 enantiomers of a-ketols and acetolactates by two thiamin diphosphate-
32 Grue-Sørensen, G. and Spenser, I.D. (1988) Biosynthesis of ephedrine. dependent decarboxylases. Bioorg. Chem. 34, 380–393
J. Am. Chem. Soc. 110, 3714–3715 59 Gunawan, C. et al. (2006) Yeast pyruvate decarboxylases: variation in
33 Grue-Sørensen, G. and Spenser, I.D. (1989) The biosynthesis of biocatalytic characteristics for (R)-phenylacetylcarbinol production.
ephedrine. Can. J. Chem. 67, 998–1009 FEMS Yeast Res. 7, 33–39
34 Grue-Sørensen, G. and Spenser, I.D. (1994) Biosynthetic route to the 60 Smallrige, N. et al. Victoria University of Technology and Polychip
Ephedra alkaloids. J. Am. Chem. Soc. 116, 6195–6200 Pharmaceuticals Pty. Methods for the synthesis of amines such as
35 Mu¨ ller, M. et al. (2009) Thiamin diphosphate in biological chemistry: ephedrine and intermediates. 7176332 B2
exploitation of diverse thiamin diphosphate-dependent enzymes for 61 Keasling, J.D. (2010) Manufacturing molecules through metabolic
asymmetric chemoenzymatic synthesis. FEBS J. 276, 2894–2904 engineering. Science 330, 1355–1358
411
Review Trends in Plant Science July 2012, Vol. 17, No. 7
62 Minami, H. et al. (2008) Microbial production of plant retrospective claims-based analysis of a managed care population.
benzylisoquinoline alkaloids. Proc. Natl. Acad. Sci. U.S.A. 105, Curr. Med. Res. Opin. 26, 977–989
7393–7398 80 Mendelson, J.E. et al. (2008) The clinical pharmacology of intranasal
63 Hawkins, K.M. and Smolke, C.D. (2008) Production of l-methamphetamine. BMC Clin. Pharm. 8, 1–9
benzylisoquinoline alkaloids in Saccharomyces cerevisiae. Nat. 81 Moreira, R. (2011) The efficacy and tolerability of bupropion in the
Chem. Biol. 4, 564–573 treatment of major depressive disorder. Clin. Drug Investig. 31 S1,
64 Nakagawa, A. et al. (2011) A bacterial platform for fermentative 5–17
production of plant alkaloids. Nat. Comm. 2, 1–8 82 Raupach, T. and van Schayck, C.P. (2011) Pharmacotherapy for
65 Anthony, J.R. et al. (2009) Optimization of the mevalonate-based smoking cessation. CNS Drugs 25, 371–382
isoprenoid biosynthetic pathway in Escherichia coli for production of 83 Naoi, M. and Maruyama, W. (2010) Monoamine oxidase inhibitors as
the anti-malarial drug precursor amorpha-4,11-diene. Metabol. Eng. neuroprotective agents in age-dependent neurodegenerative disorders.
11, 13–19 Curr. Pharm. Des. 16, 2799–2817
66 Kumaran Ajikumar, P. et al. (2010) Isoprenoid pathway optimization for 84 Ioannides-Demos, L.L. et al. (2011) Pharmacotherapies for obesity:
taxol precursor overproduction in Escherichia coli. Science 330, 70–74 past, current and future therapies. J. Obes. DOI: 10.1155/2011/179674
67 Lee, Y.L. et al. (2009) Metabolic engineering of microorganisms: 85 Mohta, M. et al. (2010) Comparison of phenylephrine hydrochloride
general strategies and drug production. Drug Discov. Today 14, 78–88 and mephentermine sulfate for prevention of post spinal hypotension.
68 Damude, H.G. et al. (2006) Identification of bifunctional d12/v3 fatty Anaesthesia 65, 1200–1205
acid desaturases for improving the ratio of v3 to v6 fatty acids in 86 Xiao, Y. et al. (2011) Study of IspH, a key enzyme in the
microbes and plants. Proc. Natl. Acad. Sci. U.S.A. 103, 9446–9451 methylerythritol phosphate pathway using fluoro-substituted
69 Damude, H.G. et al. Du Pont. High eicosapentaenoic acid–producing substrate analogues. Org. Lett. 13, 5912–5915
strains of Yarrowia lipolytica. 20110086919 87 Thomas, L.A. et al. (1997) Cholylglycine hydrolase and 7a-
70 Zhang, F. et al. (2011) Metabolic engineering of microbial pathways for dehydroxylase optimum assay conditions in vitro and caecal enzyme
advanced biofuels production. Curr. Opin. Biotechnol. 22, 1–9 activities ex vivo. Clin. Chim. Acta 268, 61–72
71 Thomas, C.J. (2006) Fluorinated natural products with clinical 88 Kai, K. et al. (2008) Scopoletin is biosynthesized via ortho-
significance. Curr. Top. Med. Chem. 6, 1529–1543 hydroxylation of feruloyl-CoA by a 2-oxoglutarate-dependent
72 Runguphan, W. et al. (2010) Integrating carbon-halogen bond dioxygenase in Arabidopsis thaliana. Plant J. 55, 989–999
formation into medicinal plant metabolism. Nature 468, 461–467 89 Sukumaran, J. and Hanefeld, U. (2005) Enantioselective C–C bond
73 Glenn, W.S. et al. (2011) Reengineering a tryptophan halogenase to synthesis catalysed by enzymes. Chem. Soc. Rev. 34, 530–542
preferentially chlorinate a direct alkaloid precursor. J. Am. Chem. Soc. 90 Ro, D-K. et al. (2006) Production of the antimalarial drug precursor
133, 19346–19349 artemisinic acid in engineered yeast. Nature 440, 940–943
74 Runguphan, W. and O’Connor, S.E. (2009) Metabolic reprogramming of 91 Leonard, L. et al. (2009) Opportunities in metabolic engineering to
periwinkle plant culture. Nat. Chem. Biol. 5, 151–153 facilitate scalable alkaloid production. Nat. Chem. Biol. 5, 292–300
75 Ward, J. and Wohlgemuth, R. (2010) High-yield biocatalytic amination 92 Krizevski, R. et al. (2012) Benzaldehyde is a precursor to
reactions in organic synthesis. Curr. Org. Chem. 14, 1914–1927 phenylproplyamino alkaloids as revealed by targeted metabolic
76 Ingram, C.U. et al. (2006) One-pot synthesis of amino-alcohols using a profiling and comparative biochemical analyses in Ephedra spp.
de-novo transketolase and b-alanine:pyruvate transaminase pathway Phytochemistry, http://dx.doi.org/10.1016/j.phytochem.2012.05.018
in Escherichia coli. Biotechnol. Bioeng. 96, 559–569 93 Abd El-Mawla, A.M.A. and Beerhues, L. (2002) Benzoic acid
77 Rosche, B. et al. (2004) Role of pyruvate in enhancing pyruvate biosynthesis in cell cultures of Hypericum androsaemum. Planta
decarboxylase stability towards benzaldehyde. J. Biotechnol. 115, 91–99 214, 727–733
78 Mun˜ oz, L. et al. (2011) Enzymatic enantiomeric resolution of 94 Gaid, M.M. et al. (2009) Benzaldehyde dehydrogenase from chitosan-
phenylethylamines structurally related to amphetamine. Org. treated Sorbus aucuparia cell cultures. J. Plant Physiol. 166, 1343–1349
Biomol. Chem. 9, 8171–8177 95 Beuerle, T. and Pichersky, E. (2002) Purification and characterization
79 Christensen, L. et al. (2010) Pharmacological treatment patterns of benzoate:coenzyme A ligase from Clarkia breweri. Arch. Biochem.
among patients with attention-deficit/hyperactivity disorder: Biophys. 400, 258–264
Plant Science Conferences in 2012
10th International Congress on Plant Molecular Biology
21 – 26 October, 2012
Jeju, South Korea
http://www.ipmb2012.org/
Plant Epigenetics, Stress and Evolution
29 October – 2 November, 2012
Suzhou, China
http://www.csh-asia.org/plant12.html
Royal Society meeting
Energy transduction and genome function – an evolutionary synthesis
12 – 13 November, 2012
London, UK http://royalsociety.org/events/Energy-and-genome/
------
Suggest a conference
Please use the form at http://www.cell.com/conferences/SuggestConference to suggest a
conference for Cell Press the Conference Calendar.
412